Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.59 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.47 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.47 |
| ▸ | PPARG | P37231 | 7/20 | 0.47 |
| ▸ | PPARD | Q03181 | 7/20 | 0.47 |
| ▸ | PPARA | Q07869 | 7/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.47 |
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | TLR2 | O60603 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | FABP4 | P15090 | 2/20 | 0.47 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.47 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.47 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28032298 | 1.00 | NOD1 (0.59) | NOD1ITGB3ITGA2BGPR84PPARG | |
| SCHEMBL1838471 | 1.00 | NOD1 (0.59) | NOD1ITGB3ITGA2BGPR84PPARG | |
| SCHEMBL27384071 | 1.00 | NOD1 (0.59) | NOD1ITGB3ITGA2BGPR84PPARG | |
| SCHEMBL27975875 | 1.00 | NOD1 (0.59) | NOD1ITGB3ITGA2BGPR84PPARG | |
| SCHEMBL28830122 | 1.00 | NOD1 (0.59) | NOD1ITGB3ITGA2BGPR84PPARG | |
| SCHEMBL27489837 | 1.00 | NOD1 (0.59) | NOD1ITGB3ITGA2BGPR84PPARG | |
| SCHEMBL25244619 | 0.98 | NOD1 (0.60) | NOD1ITGB3ITGA2BGPR84PPARG | |
| SCHEMBL2721132 | 0.98 | NOD1 (0.60) | NOD1ITGB3ITGA2BGPR84PPARG | |
| SCHEMBL2721131 | 0.98 | NOD1 (0.60) | NOD1ITGB3ITGA2BGPR84PPARG | |
| SCHEMBL8383011 | 0.98 | NOD1 (0.60) | NOD1ITGB3ITGA2BGPR84PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018185788-A1 | OPHTHALMIC SOLUTION OF BIMATOPROST | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) | 2018-10-11 | — | — | WO | claimed |
| US-11241443-B2 | Ophthalmic solution of bimatoprost | SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) | 2022-02-08 | — | — | US | disclosed |
| WO-2018185788-A1 | OPHTHALMIC SOLUTION OF BIMATOPROST | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) | 2018-10-11 | — | — | WO | disclosed |
| US-6291634-B1 | USED AS CHELATING AGENT, A PIGMENT DISPERSANT, A SURFACE-TREATING AGENT FOR A POWDER, TOILETRIES AND A RUST-PROOFING AGENT | AJINOMOTO CO., INC. (JP) | 2001-09-18 | — | — | US | disclosed |
| EP-0980862-A1 | Polyamino acid derivatives | Ajinomoto Co., Inc. (JP) | 2000-02-23 | — | — | EP | disclosed |
| US-5981450-A | SURFACTANT MIXTURE CONSISTS OF MONOGLYCERIDE SULFATE OR MONOGLYCERIDE ETHER SULFATES AND AMINO ACID DERIVATIVE SELECTED FROM WHEAT OR SOYA-DERIVED VEGETABLE PROTEIN HYDROLYZATE AND CONDENSATES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1999-11-09 | — | — | US | disclosed |
| EP-0276151-B1 | Dissolved composition of [benzo-1,2,4-thiadiazine]-1,1-dioxide for hair germination and hair growth promotion. | SHISEIDO COMPANY LIMITED (JP) | 1993-08-04 | — | — | EP | disclosed |
| EP-0276151-A2 | Dissolved composition of [benzo-1,2,4-thiadiazine]-1,1-dioxide for hair germination and hair growth promotion. | SHISEIDO COMPANY LIMITED (JP) | 1988-07-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11241443-B2 | Ophthalmic solution of bimatoprost | SLC38A7, SLC7A5, SSTR3 | NOD1 4754/4885ITGB3 2560/4885ITGA2B 3838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.